It was this research that led to dramatic increases in
pediatric cancer survival rates.
Not exact matches
The
survival difference between the two groups was not statistically significant, but investigators said the results point to a possible benefit of GO treatment for some
pediatric AML patients whose
cancer remained following chemotherapy.
Co-author Luke Whitesell, a
pediatric oncologist at the Whitehead Institute, says that the protein puts organisms in a bind: «HSF1 enhances
survival and stress tolerance, but there appears to be a flip side in
cancer.»
Success and a Quest - The vastly improved
survival rates among
pediatric cancer patients is one of the truly great success stories of modern medicine.
Together, the
cancers account for about 30 percent of the estimated 15,780 cases of
pediatric cancers diagnosed annually in the U.S. Five - year
survival for
pediatric patients with these
cancers is now 90 percent or better, according to the American
Cancer Society.
It is dedicated to improving the quality of life and the
survival rates of children and adolescents with
cancer, focusing on projects that support transition and survivorship programs, research and education initiatives, and
pediatric oncology camps.